CRISPR single base-editing: in silico predictions to variant clonal cell lines.
Dickson, K-A
Field, N
Blackman, T
Ma, Y
Xie, T
Kurangil, E
Idrees, S
Rathnayake, SNH
Mahbub, RM
Faiz, A
Marsh, DJ
- Publisher:
- OXFORD UNIV PRESS
- Publication Type:
- Journal Article
- Citation:
- Hum Mol Genet, 2023, 32, (17), pp. 2704-2716
- Issue Date:
- 2023-08-26
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
21374904_11656537030005671.pdf | Published version | 2.21 MB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Dickson, K-A | |
dc.contributor.author | Field, N | |
dc.contributor.author | Blackman, T | |
dc.contributor.author | Ma, Y | |
dc.contributor.author | Xie, T | |
dc.contributor.author | Kurangil, E | |
dc.contributor.author |
Idrees, S |
|
dc.contributor.author | Rathnayake, SNH | |
dc.contributor.author | Mahbub, RM | |
dc.contributor.author |
Faiz, A |
|
dc.contributor.author | Marsh, DJ | |
dc.date.accessioned | 2023-10-05T21:43:20Z | |
dc.date.available | 2023-06-09 | |
dc.date.available | 2023-10-05T21:43:20Z | |
dc.date.issued | 2023-08-26 | |
dc.identifier.citation | Hum Mol Genet, 2023, 32, (17), pp. 2704-2716 | |
dc.identifier.issn | 0964-6906 | |
dc.identifier.issn | 1460-2083 | |
dc.identifier.uri | http://hdl.handle.net/10453/172521 | |
dc.description.abstract | Engineering single base edits using CRISPR technology including specific deaminases and single-guide RNA (sgRNA) is a rapidly evolving field. Different types of base edits can be constructed, with cytidine base editors (CBEs) facilitating transition of C-to-T variants, adenine base editors (ABEs) enabling transition of A-to-G variants, C-to-G transversion base editors (CGBEs) and recently adenine transversion editors (AYBE) that create A-to-C and A-to-T variants. The base-editing machine learning algorithm BE-Hive predicts which sgRNA and base editor combinations have the strongest likelihood of achieving desired base edits. We have used BE-Hive and TP53 mutation data from The Cancer Genome Atlas (TCGA) ovarian cancer cohort to predict which mutations can be engineered, or reverted to wild-type (WT) sequence, using CBEs, ABEs or CGBEs. We have developed and automated a ranking system to assist in selecting optimally designed sgRNA that considers the presence of a suitable protospacer adjacent motif (PAM), the frequency of predicted bystander edits, editing efficiency and target base change. We have generated single constructs containing ABE or CBE editing machinery, an sgRNA cloning backbone and an enhanced green fluorescent protein tag (EGFP), removing the need for co-transfection of multiple plasmids. We have tested our ranking system and new plasmid constructs to engineer the p53 mutants Y220C, R282W and R248Q into WT p53 cells and shown that these mutants cannot activate four p53 target genes, mimicking the behaviour of endogenous p53 mutations. This field will continue to rapidly progress, requiring new strategies such as we propose to ensure desired base-editing outcomes. | |
dc.format | ||
dc.language | eng | |
dc.publisher | OXFORD UNIV PRESS | |
dc.relation | http://purl.org/au-research/grants/nhmrc/APP2019296 | |
dc.relation | http://purl.org/au-research/grants/nhmrc/GNT2019296 | |
dc.relation.ispartof | Hum Mol Genet | |
dc.relation.isbasedon | 10.1093/hmg/ddad105 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 06 Biological Sciences, 11 Medical and Health Sciences | |
dc.subject.classification | Genetics & Heredity | |
dc.subject.classification | 3105 Genetics | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Gene Editing | |
dc.subject.mesh | CRISPR-Cas Systems | |
dc.subject.mesh | RNA, Guide, CRISPR-Cas Systems | |
dc.subject.mesh | Tumor Suppressor Protein p53 | |
dc.subject.mesh | Clustered Regularly Interspaced Short Palindromic Repeats | |
dc.subject.mesh | Cell Line | |
dc.subject.mesh | Adenine | |
dc.subject.mesh | Cytosine | |
dc.subject.mesh | Cell Line | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Cytosine | |
dc.subject.mesh | Adenine | |
dc.subject.mesh | Tumor Suppressor Protein p53 | |
dc.subject.mesh | CRISPR-Cas Systems | |
dc.subject.mesh | Clustered Regularly Interspaced Short Palindromic Repeats | |
dc.subject.mesh | Gene Editing | |
dc.subject.mesh | RNA, Guide, CRISPR-Cas Systems | |
dc.title | CRISPR single base-editing: in silico predictions to variant clonal cell lines. | |
dc.type | Journal Article | |
utslib.citation.volume | 32 | |
utslib.location.activity | England | |
utslib.for | 06 Biological Sciences | |
utslib.for | 11 Medical and Health Sciences | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/DVC (International) | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science | |
pubs.organisational-group | /University of Technology Sydney/Strength - CHT - Health Technologies | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science/School of Life Sciences | |
pubs.organisational-group | /University of Technology Sydney/DVC (International)/Australia-China Relations Institute | |
pubs.organisational-group | /University of Technology Sydney/Centre for Health Technologies (CHT) | |
pubs.organisational-group | /University of Technology Sydney/Strength - CFI - Centre for Inflammation | |
utslib.copyright.status | closed_access | * |
dc.date.updated | 2023-10-05T21:43:19Z | |
pubs.issue | 17 | |
pubs.publication-status | Published | |
pubs.volume | 32 | |
utslib.citation.issue | 17 |
Abstract:
Engineering single base edits using CRISPR technology including specific deaminases and single-guide RNA (sgRNA) is a rapidly evolving field. Different types of base edits can be constructed, with cytidine base editors (CBEs) facilitating transition of C-to-T variants, adenine base editors (ABEs) enabling transition of A-to-G variants, C-to-G transversion base editors (CGBEs) and recently adenine transversion editors (AYBE) that create A-to-C and A-to-T variants. The base-editing machine learning algorithm BE-Hive predicts which sgRNA and base editor combinations have the strongest likelihood of achieving desired base edits. We have used BE-Hive and TP53 mutation data from The Cancer Genome Atlas (TCGA) ovarian cancer cohort to predict which mutations can be engineered, or reverted to wild-type (WT) sequence, using CBEs, ABEs or CGBEs. We have developed and automated a ranking system to assist in selecting optimally designed sgRNA that considers the presence of a suitable protospacer adjacent motif (PAM), the frequency of predicted bystander edits, editing efficiency and target base change. We have generated single constructs containing ABE or CBE editing machinery, an sgRNA cloning backbone and an enhanced green fluorescent protein tag (EGFP), removing the need for co-transfection of multiple plasmids. We have tested our ranking system and new plasmid constructs to engineer the p53 mutants Y220C, R282W and R248Q into WT p53 cells and shown that these mutants cannot activate four p53 target genes, mimicking the behaviour of endogenous p53 mutations. This field will continue to rapidly progress, requiring new strategies such as we propose to ensure desired base-editing outcomes.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph